市場調査レポート

商品コード

1596878

IVD受託製造の市場規模：シェア、成長分析、製品タイプ別、技術別、サービスタイプ別、地域別 - 産業予測、2024年～2031年

IVD Contract Manufacturing Market Size, Share, Growth Analysis, By Product Type, By Technology, By Service Type, By Region -Industry Forecast 2024-2031.

出版日: 2024年11月18日
発行: SkyQuest
ページ情報: 英文 194 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

IVD受託製造の世界市場規模は2022年に148億米ドルと評価され、2023年の165億2,000万米ドルから2031年には397億4,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは11.60％で成長する見通しです。

体外診断薬（IVD）受託製造市場は、遺伝子発現、バイオマーカー探索、標的治療を含む個別化医療への注目の高まりに大きく後押しされ、大きく成長する見通しです。この動向は、特に新興市場においてヘルスケア費用が高騰を続ける中、標準化された診断ソリューションに対する需要が増加していることが後押ししています。この市場拡大の主な要因には、デジタル病理学、次世代シーケンシング、革新的な画像技術などの診断技術の進歩が含まれ、より正確な診断製品の開発を支援しています。IVDは、個別化された妊娠検査から糖尿病管理のための血糖値モニタリングまで、多様なアプリケーションを包含しており、それによって市場の訴求力を高めています。さらに、製薬業界では体外診断用医薬品への依存度が高まっており、エンドユーザーへの普及が進んでいます。また、タイムリーな検査、診断、疾病予防を促進するポイント・オブ・ケア・モニタリング・デバイスに対する関心の高まりも顕著です。この動向は、高速診断機器のカスタマイズが普及するにつれて進展すると予想されます。さらに、多くの市場関係者がこの分野の成長を強化する戦略の実行に積極的に取り組んでおり、市場セグメンテーション市場の軌道をさらに強固なものにしています。情勢が進展する中、こうした動向に沿った利害関係者は、拡大する市場において大きなビジネスチャンスを獲得する可能性が高いです。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東およびアフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Jabil Inc.
Sanmina Corporation
TE Connectivity
Celestica, Inc.
West Pharmaceutical Services, Inc.
Savyon Diagnostics, Ltd.
KMC Systems
Cenogenics Corporation
Nova Biomedical
Cone Bioproducts
Kimball Electronics, Inc.
Roche Diagnostics
Viant Medical Holdings, Inc.
Sysmex Corporation
Stratec SE
Thermo Fisher Scientific, Inc.
Fujirebio
Biokit（Werfen）
Sekisui
Prestige Diagnostics

結論と推奨事項

Product Code: SQMIG35H2317

Global IVD Contract Manufacturing Market size was valued at USD 14.80 billion in 2022 and is poised to grow from USD 16.52 billion in 2023 to USD 39.74 billion by 2031, growing at a CAGR of 11.60% during the forecast period (2024-2031).

The in vitro diagnostics (IVD) contract manufacturing market is poised for significant growth, largely fueled by the rising focus on personalized medicine, which encompasses gene expression, biomarker discovery, and targeted therapies. This trend is bolstered by the increasing demand for standardized diagnostic solutions as healthcare costs continue to escalate, particularly in emerging markets. Key drivers of this market expansion include advancements in diagnostic technologies such as digital pathology, next-generation sequencing, and innovative imaging techniques, which aid in the development of more accurate diagnostic products. IVDs encompass a diverse array of applications, from personalized pregnancy tests to blood glucose monitoring for diabetes management, thereby broadening their market appeal. Furthermore, the pharmaceutical industry's growing reliance on IVD devices amplifies their adoption among end users. There is also a notable surge in interest surrounding point-of-care monitoring devices, which facilitate timely testing, diagnosis, and disease prevention. This trend is expected to progress as customization in high-speed diagnostic devices becomes more prevalent. Additionally, numerous market players are actively engaged in executing strategies that enhance growth in this segment, further solidifying the IVD contract manufacturing market's trajectory. As the landscape evolves, stakeholders who align with these trends are likely to capture significant opportunities within the expanding market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ivd Contract Manufacturing Market Segmental Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region. By Product Type, the market is classified into Consumables, and Equipment. Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies. According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ivd Contract Manufacturing Market

The global IVD contract manufacturing market is primarily driven by the rising demand for advanced In Vitro Diagnostics (IVD) devices, fueled by the increasing prevalence of chronic illnesses, including diabetes, cancer, and heart disease. This escalating need has prompted manufacturers to enhance their productivity to tackle pressing global health challenges effectively. Additionally, contract manufacturers are pivotal in delivering cost-efficient and high-quality solutions, empowering IVD companies to comply with stringent regulatory requirements. As a result, the contract manufacturing sector is positioned to play an essential role in the healthcare ecosystem, supporting innovation and access to critical diagnostic tools worldwide.

Restraints in the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market encounters significant constraints primarily due to elevated development and manufacturing costs. Producing IVD devices demands substantial financial commitments for research, regulatory compliance, and state-of-the-art manufacturing facilities. These high expenses associated with creating innovative diagnostic technologies often deter small to medium-sized enterprises from entering the industry, thereby hindering overall market growth. The financial burden can limit the capacity of these companies to invest in necessary advancements and expertise, which could otherwise enhance their competitiveness and ability to innovate within the IVD landscape. Consequently, the market's expansion is restricted by these financial barriers.

Market Trends of the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market is increasingly witnessing a trend towards outsourcing production to emerging markets, notably in the Asia-Pacific region. This shift is driven by the allure of reduced labor costs, the availability of a skilled workforce, and the imperative to manage rising manufacturing pressures. Companies are capitalizing on these advantages to enhance operational efficiency while accessing new growth opportunities in expanding markets. This trend not only allows manufacturers to significantly lower expenses but also positions them to cater to the increasing demand for in vitro diagnostics in these dynamic regions, ultimately reshaping the industry's competitive landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
Market Attractiveness Index
Supply Chain Analysis
Pricing Analysis

Global IVD Contract Manufacturing Market Size by Product Type & CAGR (2024-2031)

Market Overview
Consumables
Equipment

Global IVD Contract Manufacturing Market Size by Technology & CAGR (2024-2031)

Market Overview
Immunoassays
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation & Hemostasis
Other Technologies

Global IVD Contract Manufacturing Market Size by Service Type & CAGR (2024-2031)

Market Overview
Manufacturing Services
Assay Development
Other Services

Global IVD Contract Manufacturing Market Size & CAGR (2024-2031)

North America, (Product Type, Technology, Service Type)
- US
- Canada
Europe, (Product Type, Technology, Service Type)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product Type, Technology, Service Type)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product Type, Technology, Service Type)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product Type, Technology, Service Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanmina Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TE Connectivity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celestica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Savyon Diagnostics, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KMC Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cenogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cone Bioproducts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimball Electronics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratec SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujirebio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biokit (Werfen)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

IVD受託製造の市場規模：シェア、成長分析、製品タイプ別、技術別、サービスタイプ別、地域別 - 産業予測、2024年～2031年

IVD Contract Manufacturing Market Size, Share, Growth Analysis, By Product Type, By Technology, By Service Type, By Region -Industry Forecast 2024-2031.

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

IVD受託製造の市場規模：製品タイプ別

IVD受託製造の市場規模：技術別

IVD受託製造の市場規模：サービスタイプ別

IVD受託製造の市場規模：地域別